Enter Your Search:
Results 1-3 (3)
Go to page number:
Select a Filter Below
Journal of Clinical Investigation (1)
Coschigano, Karen (2)
Kopchick, John (2)
Baron, Roland (1)
Bartke, Andrzej (1)
Binart, Nadine (1)
Bouali, Yasmina (1)
Brown-Borg, Holly (1)
Clément-Lacroix, Philippe (1)
Coschigano, Karen T. (1)
Da Ponte, Francesca (1)
Gaillard-Kelly, Martine (1)
Goffin, Vincent (1)
Hauck, Steven (1)
Kelly, Paul A. (1)
Kinney, Beth (1)
Mattison, Julie (1)
Moriggl, Richard (1)
Sims, Natalie A. (1)
Wright, Chris (1)
Year of Publication
Aging-related characteristics of growth hormone receptor/binding protein gene-disrupted mice
Since generation of the growth hormone receptor/binding protein (GHR/BP) gene-disrupted mouse nearly 10 years ago, use of this mouse model has become widespread in the elucidation of the physiological roles of GH and insulin-like growth factor-1 (IGF-1). In particular, it serves as a useful model to study mechanisms of aging. This review highlights the evidence demonstrating that the loss of GH signaling leads to lifespan extension in mice, and presents the multiple characteristics of this mouse line that suggest the life extension is due to alteration of the aging process.
aging; gene disruption; growth hormone receptor/binding protein; longevity; mice
Growth hormone and aging
The potential usefulness of growth hormone (GH) as an anti-aging therapy is of considerable current interest. Secretion of GH normally declines during aging and administration of GH can reverse age-related changes in body composition. However, mutant dwarf mice with congenital GH deficiency and GH resistant GH-R-KO mice live much longer than their normal siblings, while a pathological elevation of GH levels reduces life expectancy in both mice and men. We propose that the actions of GH on growth, development, and adult body size may serve as important determinants of aging and life span, while the age-related decline in GH levels contributes to some of the symptoms of aging.
Bone homeostasis in growth hormone receptor–null mice is restored by IGF-I but independent of Stat5
Sims, Natalie A.
Da Ponte, Francesca
Kelly, Paul A.
Journal of Clinical Investigation
Growth hormone (GH) regulates both bone growth and remodeling, but it is unclear whether these actions are mediated directly by the GH receptor (GHR) and/or IGF-I signaling. The actions of GH are transduced by the Jak/Stat signaling pathway via Stat5, which is thought to regulate IGF-I expression. To determine the respective roles of GHR and IGF-I in bone growth and remodeling, we examined bones of wild-type, GHR knockout (GHR–/–), Stat5ab–/–, and GHR–/– mice treated with IGF-I. Reduced bone growth in GHR–/– mice, due to a premature reduction in chondrocyte proliferation and cortical bone growth, was detected after 2 weeks of age. Additionally, although trabecular bone volume was unchanged, bone turnover was significantly reduced in GHR–/– mice, indicating GH involvement in the high bone-turnover level during growth. IGF-I treatment almost completely rescued all effects of the GHR–/– on both bone growth and remodeling, supporting a direct effect of IGF-I on both osteoblasts and chondrocytes. Whereas bone length was reduced in Stat5ab–/– mice, there was no reduction in trabecular bone remodeling or growth-plate width as observed in GHR–/– mice, indicating that the effects of GH in bone may not involve Stat5 activation.
Results 1-3 (3)
Go to page number:
Remove citation from clipboard
Add citation to clipboard
This will clear all selections from your clipboard. Do you wish proceed?
Clipboard is full! Please remove an item and try again.
PubMed Central Canada is a service of the
Canadian Institutes of Health Research
(CIHR) working in partnership with the National Research Council's
Canada Institute for Scientific and Technical Information
in cooperation with the
National Center for Biotechnology Information
U.S. National Library of Medicine
(NCBI/NLM). It includes content provided to the
PubMed Central International archive
by participating publishers.